Abstract:E3 ligases, essential components of the ubiquitin-proteasome-mediated protein degradation system, play a critical role in cellular regulation. By covalently attaching ubiquitin (Ub) molecules to target proteins, these ligases mark them for degradation, influencing various bioprocesses. With over 600 E3 ligases identified, there is a growing realization of their potential as therapeutic candidates for addressing proteinopathies in cancer and neurodegenerative disorders (NDDs). Recent research has highlighted the need to delve deeper into the intricate roles of E3 ligases as nexus points in the pathogenesis of both cancer and NDDs. Their dysregulation is emerging as a common thread linking these seemingly disparate diseases, necessitating a comprehensive understanding of their molecular intricacies. Herein, we have discussed (i) the fundamental mechanisms through which different types of E3 ligases actively participate in selective protein degradation in cancer and NDDs, followed by an examination of common E3 ligases playing pivotal roles in both situations, emphasising common players. Moving to, (ii) the functional domains and motifs of E3 ligases involved in ubiquitination, we have explored their interactions with specific substrates in NDDs and cancer. Additionally, (iii) we have explored techniques like PROTAC, molecular glues, and other state-of-the-art methods for hijacking neurotoxic and oncoproteins. Lastly, (iv) we have provided insights into ongoing clinical trials, offering a glimpse into the evolving landscape of E3-based therapeutics for cancer and NDDs. Unravelling the intricate network of E3 ligase-mediated regulation holds the key to unlocking targeted therapies that address the specific molecular signatures of individual patients, heralding a new era in personalized medicines.

Progress in Structural and Functional Study of Ubiquitin Ligases

Structural Diversity of Ubiquitin E3 Ligase

Functional Dissection of a HECT Ubiquitin E3 Ligase

Targeted Modulation of E3 Ligases Using Engineered Ubiquitin Variants.

The Ubiquitylation System: Targeting Proteins for Degradation and Beyond

Cullin-RING E3 Ubiquitin Ligases: Bridges to Destruction.

[Progress in Ubiquitin, Ubiquitin Chain and Protein Ubiquitination].

Structural Visualization of HECT-E3 Ufd4 accepting and transferring Ubiquitin to Form K29/K48-branched Polyubiquitination on N-degron

Research Progress of UbiquitinL igase Complex KPC

Getting into position: the catalytic mechanisms of protein ubiquitylation

Immune regulation by ubiquitin conjugation.

A General Strategy for Discovery of Inhibitors and Activators of RING and U-box E3 Ligases with Ubiquitin Variants

E3 Ubiquitin Ligases in Cancer and Implications for Therapies

Progress of research on the ubiquitin-proteasome system and its non-degradation function

Ubiquitination Enzymes

Ubiquitin ligases and the immune response.

Structural Aspects of Ubiquitin Binding Specificities

Structure of a RING E3 ligase and ubiquitin-loaded E2 primed for catalysis

Allosteric Regulation of E2:E3 Interactions Promote A Processive Ubiquitination Machine

Mechanistic insights into the enzymatic activity of E3 ligase HOIL-1L and its regulation by the linear ubiquitin chain binding

Ubiquitin E3 ligases assisted technologies in protein degradation: Sharing Pathways in Neurodegenerative Disorders and Cancer